No products in the cart.
Novo’s Nanexa Deal Reshapes Pharma Career Landscape
Novo Nordisk's recent $1.3 billion deal with Nanexa marks a pivotal moment for biotech…
Novo Nordisk's recent $1.3 billion deal with Nanexa marks a pivotal moment for biotech…
Novo Nordisk, the maker of the obesity drug Ozempic, is launching a series of incubators across…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.